Ignasi Rodríguez-Pintó Selected Research

Antibodies

1/2015

Catastrophic APS in the context of other thrombotic microangiopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ignasi Rodríguez-Pintó Research Topics

Disease

8	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2022 - 09/2013
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2022 - 01/2016
4	Thrombosis (Thrombus) 11/2019 - 09/2017
3	Thrombotic Microangiopathies 09/2022 - 01/2015
2	Infections 01/2018 - 01/2015
1	deficiency of adenosine deaminase 2 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018
1	Fever (Fevers) 07/2015
1	Atypical Hemolytic Uremic Syndrome 01/2015
1	Malignant Hypertension 01/2015
1	Neoplasms (Cancer) 01/2015
1	Thrombotic Thrombocytopenic Purpura 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Giant Cell Arteritis (Horton Disease) 06/2014

Drug/Important Bio-Agent (IBA)

6	Antiphospholipid AntibodiesIBA 09/2022 - 07/2014
2	Complement System Proteins (Complement)IBA 09/2022 - 04/2022
2	CytokinesIBA 01/2018 - 09/2017
2	Pharmaceutical PreparationsIBA 01/2016 - 01/2015
1	eculizumab FDA Link 04/2022
1	Adenosine DeaminaseIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Endothelial Protein C ReceptorIBA 01/2018
1	C-Reactive ProteinIBA 07/2015
1	anti-dsDNA autoantibodyIBA 07/2015
1	AntibodiesIBA 01/2015
1	Heparin (Liquaemin)FDA LinkGeneric 01/2015
1	Platelet Factor 4IBA 01/2015
1	thiamine triphosphorate (TTP)IBA 01/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2014
1	Angiotensin Receptor AntagonistsIBA 06/2014
1	Rituximab (Mabthera)FDA Link 09/2013

Therapy/Procedure

3	Therapeutics 04/2022 - 07/2018
1	Plasma Exchange 11/2019
1	Operative Surgical Procedures 01/2018